Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
EULAR Rheumatology Open|June 29, 2026
Low value of routine serological screening for hepatitis B in patients with rheumatoid arthritis starting rituximab therapy in a nonendemic regionPauline M Bovens, Maike Hm Wientjes, Nathan den Broeder, et al.
Arthritis Research & Therapy|November 30, 2013
Very different performance of the power Doppler modalities of several ultrasound machines ascertained by a microvessel flow phantomDavid F Ten Cate, Jolanda J Luime, Myrthe van der Ven, et al.
Clinical Rheumatology|June 24, 2014
A comparison between ultrasonographic, surgical and histological assessment of tenosynovits in a cohort of idiopathic carpal tunnel syndrome patientsDavid F Ten Cate, Nick Glaser, Jolanda J Luime, et al.
Rheumatology (Oxford, England)|August 24, 2022
Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritisCéleste J T van der Togt, David F Ten Cate, Bart J F van den Bemt, et al.
Rheumatology (Oxford, England)|April 4, 2022
Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritisCéleste J T van der Togt, David F Ten Cate, Nathan den Broeder, et al.
Clinical and Experimental Rheumatology|July 11, 2012
The most reliable probe position in the ultrasonographic examination of the wrist in rheumatoid arthritisNoelia Dopazo González, David F Ten Cate, Wijnand A A Swen, et al.
Rheumatology (Oxford, England)|February 15, 2026
Measurement properties of the Polymyalgia Rheumatica Activity Score (PMR-AS): reliability, measurement error and discriminative validityNoortje E S E P Kooijman, David F Ten Cate, Pauline M E T Bovens, et al.
Arthritis Research & Therapy|January 10, 2013
Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis--a systematic review of the literatureDavid F Ten Cate, Jolanda J Luime, Nanno Swen, et al.
Clinical Pharmacology and Therapeutics|October 23, 2025
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do MatterAmy C D Peeters, Maike H M Wientjes, Wieland D Müskens, et al.
Rheumatology (Oxford, England)|June 10, 2022
Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cellsMerel A A Opdam, J H de Leijer, Nathan den Broeder, et al.
Pageof 2